<DOC>
	<DOCNO>NCT00888823</DOCNO>
	<brief_summary>A new type treatment call stereotactic radiotherapy recently develop hope improve success treatment improve convenience patient , reduce side effect . This study develop stereotactic radiotherapy state-of-the-art treatment lung cancer patient .</brief_summary>
	<brief_title>Phase I/II Study Fractionated Stereotactic Radiotherapy Early Stage Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary Objectives - To determine efficacy hypofractionated , image guide radiotherapy treating patient lung tumour , primary outcome local control one year . - To determine toxicity high dose , small field , hypofractionated radiotherapy lung , base RTOG CTCAE scale .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>T1T3N0 nonsmall cell lung cancer ( maximum dimension 5cm , T3 chestwall involvement ) Medically inoperable due comorbid condition patient preference radiation adequate pulmonary function withstand radical treatment ( ie . FEV1 great 40 % predict ) , assess consult radiation oncologist age great equal 18 , Karnofsky performance status great equal 70 Presence mediastinal metastasis distant metastasis Life expectancy less 1 year due comorbid condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Fractionated stereotactic radiotherapy</keyword>
	<keyword>Medically inoperable</keyword>
	<keyword>Image-guided radiotherapy</keyword>
</DOC>